Status:
UNKNOWN
Study of Topically Applied Green Tea Extract for Radio Dermatitis and Radiation Mucositis
Lead Sponsor:
Shandong Cancer Hospital and Institute
Conditions:
Epigallocatechin Gallate
Radio Dermatitis
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
PHASE2
Brief Summary
Radiodermatitis and radiation mucositis were the most frequent side-effect during the course of radiotherapy, especially when concurrent chemoradiotherapy applied. Since reactive oxygen species formed...
Detailed Description
The phase 1 trial using EGCG for prevention and treatment radiodermatitis in patients with breast cancer. Patient selection criteria The eligible criteria including: ≥18 years old; adequate renal and...
Eligibility Criteria
Inclusion
- ≥18 years old
- with histologically proven cancer
- receive external radiotherapy or concurrent chemoradiotherapy
Exclusion
- previous radiotherapy
- previous chemotherapy for another neoplasia
- pregnancy or lactation
- a known allergy or hypersensitivity to EGCG
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01481818
Start Date
September 1 2011
End Date
August 1 2022
Last Update
April 28 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.